![]() The reason that Allergan and the Tribe engaged in this deal is not a secret. Last week, EFF and Public Knowledge explained to the Patent Office how Allergan and the Tribe’s deal doesn’t mean Allergan’s bad patents can’t be challenged. Instead, Allergan paid the Tribe $13.75 million, and also agreed to pay the Tribe up to $15 million more each year in exclusive licensing fees. But this was not a usual “sale.” The Tribe doesn’t appear to have paid anything in exchange for becoming the legal owner of Allergan’s patents. On September 8, 2017, the multi-billion dollar pharmaceutical company Allergan announced that it “sold” its patents relating to its eye drops drug “Restasis” to the Saint Regis Mohawk Tribe. The other day, the EFF’s Vera Ranieri wrote about how Native Americans are still being exploited for a patent “scam”, as some people call it (the proper description of it is PTAB dodge, misusing tribal immunity that’s an exception to ordinary law). None of these seems potent, but it’s worth keeping an eye and a log. PTAB, however, may face some other perils/hurdles/obstacles. Almost nobody cares and PTAB foes appear to have accepted, based on oral proceedings, that PTAB will endure. ![]() THE TRIAL which has PTAB hanging on the balance is no longer being covered. Summary: The Patent Trial and Appeal Board (PTAB), based on the latest news, is still winning the argument and justifying its existence/importance ![]() Posted in America, Patents at 2:11 pm by Dr. The Patent Trial and Appeal Board Will Endure Supreme Court Test and Overcome the Tribal Immunity “Scam” ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |